This article has been updated to clarify CMS's initial determination on the reimbursement process for AMA's new molecular pathology test codes.
NEW YORK (GenomeWeb News) – The Centers for Medicare & Medicaid Services last week issued a preliminary decision to place new Current Procedural Terminology codes for molecular diagnostics that it determines fall under its clinical laboratory fee schedule to be reimbursed via the so-called "gapfill" process.